151 related articles for article (PubMed ID: 17616695)
1. Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint.
Magnaghi-Jaulin L; Eot-Houllier G; Fulcrand G; Jaulin C
Cancer Res; 2007 Jul; 67(13):6360-7. PubMed ID: 17616695
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors induce mitotic slippage.
Stevens FE; Beamish H; Warrener R; Gabrielli B
Oncogene; 2008 Feb; 27(10):1345-54. PubMed ID: 17828304
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation.
Shin HJ; Baek KH; Jeon AH; Kim SJ; Jang KL; Sung YC; Kim CM; Lee CW
Oncogene; 2003 Jun; 22(25):3853-8. PubMed ID: 12813458
[TBL] [Abstract][Full Text] [Related]
4. Analysis of checkpoint responses to histone deacetylase inhibitors.
Beamish H; Warrener R; Gabrielli BG
Methods Mol Biol; 2004; 281():245-59. PubMed ID: 15220534
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells.
Stolz A; Vogel C; Schneider V; Ertych N; Kienitz A; Yu H; Bastians H
Cancer Res; 2009 May; 69(9):3874-83. PubMed ID: 19366805
[TBL] [Abstract][Full Text] [Related]
6. The spindle checkpoint in the dinoflagellate Crypthecodinium cohnii.
Yeung PK; New DC; Leveson A; Yam CH; Poon RY; Wong JT
Exp Cell Res; 2000 Jan; 254(1):120-9. PubMed ID: 10623472
[TBL] [Abstract][Full Text] [Related]
7. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.
Noh EJ; Lim DS; Jeong G; Lee JS
Biochem Biophys Res Commun; 2009 Jan; 378(3):326-31. PubMed ID: 19038231
[TBL] [Abstract][Full Text] [Related]
8. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Ueda T; Takai N; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
[TBL] [Abstract][Full Text] [Related]
9. A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation.
Hall LL; Th'ng JP; Guo XW; Teplitz RL; Bradbury EM
Cancer Res; 1996 Aug; 56(15):3551-9. PubMed ID: 8758926
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors: molecular mechanisms of action.
Xu WS; Parmigiani RB; Marks PA
Oncogene; 2007 Aug; 26(37):5541-52. PubMed ID: 17694093
[TBL] [Abstract][Full Text] [Related]
11. Prospects: histone deacetylase inhibitors.
Dokmanovic M; Marks PA
J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937
[TBL] [Abstract][Full Text] [Related]
12. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylase 3 produces mitotic defects independent of alterations in histone H3 lysine 9 acetylation and methylation.
Warrener R; Chia K; Warren WD; Brooks K; Gabrielli B
Mol Pharmacol; 2010 Sep; 78(3):384-93. PubMed ID: 20562223
[TBL] [Abstract][Full Text] [Related]
14. FK228 induces mitotic catastrophe in A549 cells by mistargeting chromosomal passenger complex localization through changing centromeric H3K9 hypoacetylation.
Zhang X; Zhang Z; Chen G; Zhao M; Wang D; Zhang X; Du Z; Xu Y; Yu X
Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):677-87. PubMed ID: 20817931
[TBL] [Abstract][Full Text] [Related]
15. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells.
Gensert JM; Baranova OV; Weinstein DE; Ratan RR
Neurobiol Dis; 2007 Jun; 26(3):671-80. PubMed ID: 17481908
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
Frew AJ; Johnstone RW; Bolden JE
Cancer Lett; 2009 Aug; 280(2):125-33. PubMed ID: 19359091
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells.
Lindström TM; Mohan AR; Johnson MR; Bennett PR
Mol Pharmacol; 2008 Jul; 74(1):109-21. PubMed ID: 18375836
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2008 Jan; 21(1):109-15. PubMed ID: 18097623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
